Skip to content

Author

S. Gurská

We have 4 of 90 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

#protein folding Open access Oct 2026

Design, Synthesis, and Biological Evaluation of 1 H -Pyrrolo[3,2- c ]quinolines as Potent and Selective Antitubulin Agents Active against Drug-Resistant Cell Lines

A library of 1H-pyrrolo[3,2-c]quinolines (PQs) was synthesized, and SAR analysis identified compounds with low-nanomolar potency in CCRF-CEM cells (IC50 = 13−18 nM) and selectivity indices > 1000-fold over BJ fibroblasts. The most active derivatives retained activity against daunorubicin-resistant and paclitaxel-resi...

P. Králová, Jiří Řehulka, K. Grychowska et al. · 0 citations
Open access Sep 2026

Design, synthesis, molecular docking and anticancer activity of novel N-(4-(chlorodifluoromethoxy)phenyl)-1H-pyrrolo[2,3-b]pyridine-5-carboxamide derivatives

Results suggest that the N-(4-(chlorodifluoromethoxy)phenyl)-1H-pyrrolo[2,3-b]pyridine-5-carboxamide scaffold is a useful template for designing selective BCR-ABL1-directed anticancer agents, with compound 9c as an encouraging lead for further optimisation and mechanistic studies.

Pradeep B. Bhise, Sandeep B. Bhise, Somnath Dasgupta et al. · 0 citations
Open access Aug 2026

New 1,2,3‐Triazole Hybrids as Anticancer Agents: Design, Synthesis, Characterization, and In Silico Studies

Both in vitro and computational analyses demonstrated that compounds 11, 12, and 13 exhibit high affinity for the A Cα subunit of protein kinase A, suggesting a kinase‐targeted mechanism of action, providing a structural foundation for future design strategies to optimize the potency of these lead compounds.

A. Suárez, Katiuska Chávez, Pablo Martínez et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.